Under construction – not a live service
Sign in

Macular degeneration: open trials in China

36 open trials have a site in China. Registry data; only the trial team decides who can take part.

  • NCT06737354

    Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD).

    Trial Treatment · Phase 1 · InnoVec Biotherapeutics Inc.

    West China Hospital of Sichuan University, Chengdu

    Registry updated 2026-11-04

  • NCT06635148

    A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

    Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC

    Beijing Tongren Hospital CMU, Beijing · West China Hospital Si Chuan University, Chengdu · Shanghai General Hospital, Shanghai

    Registry updated 2026-11-03

  • NCT07185841

    Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD)

    Trial Treatment · Phase 1/2 · Fujian Haixi Pharmaceuticals Co., Ltd.

    Beijing Hospital, Beijing

    Registry updated 2026-10-28

  • NCT07418177

    Study in Human iPSCs-derived RPE Cells Transplantation for Advanced (Late-stage) AMD

    Trial Treatment · Phase 1/2 · The First Affiliated Hospital with Nanjing Medical University

    The First Affiliated Hospital with Nanjing Medical University, Nanjing

    Registry updated 2026-10-19

  • NCT07817615

    A Phase I Study of GenSci148 Intravitreal Injection for Neovascular Age-related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion

    Trial Treatment · Phase 1 · Changchun GeneScience Pharmaceutical Co., Ltd.

    Shanghai General Hospital, Shanghai

    Registry updated 2026-09-14

  • NCT06346600

    A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

    Research · Skyline Therapeutics

    Beijing Hospital, Beijing · Peking Union Medical College Hospital, Beijing · Zhejiang Provincial People's Hospital, Hangzhou · The Second Hospital of Anhui Medical University, Hefei · Eye ENT Hospital of Fudan University, Shanghai · Xinhua Hospital Affiliated To Shanghai Jiao tong University School of Medicine, Shanghai · Eye Hospital, WMU (Zhejiang Eye Hospital), Wenzhou

    Registry updated 2026-09-01

  • NCT05986864

    Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

    Trial Treatment · Phase 1/2 · Skyline Therapeutics (US) Inc.

    Beijing Hospital, Beijing · Peking Union Medical College Hospital, Beijing · Zhejiang Provincial People's Hospital, Hangzhou · The Second Hospital of Anhui Medical University, Hefei · Eye Hospital, WMU (Zhejiang Eye Hospital), Wenzhou

    Registry updated 2026-08-28

  • NCT07776522

    Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration

    Trial Treatment · Phase 2 · West China Hospital

    Beijing Hospital, Beijing · Peking University People's Hospital, Beijing · West China Hospital,Sichuan University, Chengdu · Southwest Hospital, Army Medical University(Southwest Hospital), Chongqing · The Second Affiliated Hospital of Harbin Medical University, Harbin · The Second Hospital of Jilin University, Jilin City · The First People's Hospital of Yunnan Province, Kunming · Jiangsu Provincial People's Hospital - The First Affiliated Hospital of Nanjing Medical University, Nanjing · Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai · Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou · Shanxi Eye Hospital, Taiyuan · Shanxi Bethune Hospital, Taiyuan · Tianjin Eye Hospital, Tianjin · General Hospital of Central Theater Command, Chinese People's Liberation Army, Wuhan · Zhejiang Provincial People's Hospital, Zhejiang · Henan Provincial People's Hospital, Zhengzhou

    Registry updated 2026-08-20

  • NCT07317934

    Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)

    Trial Treatment · Phase 3 · Innostellar Biotherapeutics Co.,Ltd

    Peking Union Medical College Hospital, Beijing · Beijing Aier-Intech Eye Hospital, Beijing · Beijing Hospital, Beijing · The Second Hospital of Jilin University, Changchun · The Second Xiangya Hospital, Central South University, Changsha · Aier Eye Hospital Group Co., LTD. Changsha Aier Eye Hospital, Changsha · Sichuan Provincial People's Hospital, Chengdu · West China Hospital,Sichuan University, Chengdu · The Second Affiliated Hospital of Chongqing Medical University, Chongqing · Southwest Hospital, Chongqing · The First Affiliated Hospital of Jinan University, Guangzhou · Zhejiang Provincial People's Hospital, Hangzhou · The Second Affiliated Hospital of Harbin Medical University, Harbin · The First Affiliated Hospital of University of Science and Technology of China, Hefei · Qilu Hospital of Shandong University, Jinan · Shandong Eye Hospital, Jinan · The Affiliated Eye Hospital of Nanjing Medical University, Nanjing · Qingdao Eye Hospital Affiliated to Shandong First Medical University, Qingdao · Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai · Eye ENT Hospital of Fudan University, Shanghai · Shanghai General Hospital, Shanghai · Xinhua Hospital Affiliated To Shanghai Jiao tong University School of Medicine, Shanghai · Joint Shantou International Eye Center, Shantou University and the Chinese University of Hong Kong, Shantou · Shenyang Fourth People's Hospital, Shenyang · Shanxi Bethune Hospital, Taiyuan · Shanxi Eye Hospital, Taiyuan · Tianjin Eye Hospital, Tianjin · Tianjin Medical University Eye Hospital, Tianjin · The Eye Hospital of Wenzhou Medical University, Wenzhou · Central Theater Command General Hospital of PLA, Wuhan · Tongji Hospital Tongji Medical College of Hust, Wuhan · Xi 'an People's Hospital (Xi 'an No.4 Hospital), Xi’an · The First Affiliated Hospital of Air Force Medical University, Xi’an · Hebei Eye Hospital, Xingtai · Xuzhou First People's Hospital, Xuzhou · Zhongshan Ophthalmic Center, Sun Yat-sen University, Zhongshan

    Registry updated 2026-08-06

  • NCT07640997

    Real-world Study of Aflibercept 8 mg in nAMD

    Research · Peking University People's Hospital

    Peking University People's Hospital, Beijing · Peking Union Medical College Hospital, Beijing · Peking University Third Hospital, Beijing · Beijing Haidian Hospital, Beijing · Beijing Friendship Hospital, Capital Medical University, Beijing · Peking University First Hospital, Beijing · Beijing Chao-Yang Hospital, Capital Medical University, Beijing · Sichuan Academy of Medical Sciences sichuan Provincial People's Hospital, Chengdu · Dalian No.3 People'S Hospital, Dalian · The First Affiliated Hospital of Fujian Medical University, Fuzhou · The 2nd Affiliated Hospital of Harbin Medical University, Harbin · The Affiliated Hospital of Inner Mongolia Medical University, Hohhot · Jinan Second People's Hospital, Jinan · Nanyang Eye Hospital, Nanyang · Ningbo Eye Hospital, Ningbo · Qingdao Eye Hospital of Shandong First Medical University, Qingdao · Shanghai Tenth People's Hospital, Shanghai · Tong Ren Hospital,Shanghai Jiao Tong University School Of Medicine, Shanghai · The Fourth People's Hospital of Shenyang, Shenyang · Shenzhen Eye Hospital, Shenzhen · Tianjin Medical University General Hospital, Tianjin · Tianjin Medical University Eye Hospital, Tianjin · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou · Tongji Hospital Tongji Medical College of Hust, Wuhan · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan · Xi'an People's Hospital, Xi’an · Affiliated Hospital of Zunyi Medical University, Zunyi

    Registry updated 2026-06-11

  • NCT07328776

    AI vs. Physician for Anti-VEGF Decision-Making: An RCT

    Trial Treatment · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai General Hospital, Shanghai · Shanghai general hospital, Shanghai Jiao Tong University, Shanghai, 200080, Shanghai

    Registry updated 2026-05-22

  • NCT07581782

    Prospective, Single Arm, Observational Study of Faricimab in the Treatment of Neovascular Age-related Macular Degeneration (nAMD)

    Research · Sun Yat-sen University

    Zhongshan Ophthalmic Center,Sun Yat-Sen University, Guangzhou

    Registry updated 2026-05-12

  • NCT07570355

    Pterygopalatine Ganglion Stimulation for the Treatment of Geographic Atrophy

    Trial Treatment · Shanghai Institute of Acupuncture, Moxibustion and Meridian

    Shanghai Research Institute of Acupuncture and Meridian, Shanghai

    Registry updated 2026-05-06

  • NCT07053358

    Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients

    Trial Treatment · Early phase 1 · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

    Registry updated 2026-03-10

  • NCT07409389

    Repeated Low-Level Red-Light Therapy in Dry Age-Related Macular Degeneration

    Trial Treatment · The Hong Kong Polytechnic University

    The Hong Kong Polytchnic University, Hong Kong

    Registry updated 2026-02-13

  • NCT07406438

    To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

    Trial Treatment · Phase 1 · Shenzhen Kexing Pharmaceutical Co., Ltd.

    Beijing Tongren Hospital, Capital Medical University, Beijing · The Affiliated Hospital of Guizhou Medical University, Guiyang · Sir Run Run Shaw Hospital (SRRSH),affiliated with Zhejiang University School of Medicine, Hangzhou · Zhejiang Provincial People's Hospital, Hangzhou · Nanchang University Second Affiliated Hospital, Nanchang · Henan Provincial Eye Hospital, Zhengzhou

    Registry updated 2026-02-12

  • NCT07365371

    A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)

    Trial Treatment · Phase 4 · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    Beijing Hospital, Beijing · Beijing Tongren Hospital CMU, Beijing · The Second People's Hospital of Foshan, Foshan · The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou · The First Affiliated Hospital of Harbin Medical University, Harbin · Jiaxing Hospital of T.C.M, Jiaxing · The Second Norman Bethune Hospital of Jilin University, Jilin City · Shandong Provincial Hospital, Jinan · The First Affiliated Hospital of Kunming Medical University, Kunming · Affiliated Eye Hospital of Nanchang University, Nanchang · Jiangsu Province Hospital (the First Affiliated Hospital With Nanjing Medical University), Nanjing · Eye ENT Hospital of Fudan University, Shanghai · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai · Shanxi Eye Hospital, Taiyuan · Tianjin Eye Hospital, Tianjin · Affiliated Hospital of Shandong Second Medical University, Weifang · Renmin Hospital of Wuhan University, Wuhan · Xi' AN No.1 Hospital, Xi'an · The First People's Hospital of Xianyang, Xianyang · The First Affiliated Hospital of Zhengzhou University, Zhengzhou

    Registry updated 2026-01-26

  • NCT07275840

    A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD

    Trial Treatment · Phase 2 · Innovent Biologics Technology Limited (Shanghai R&D Center)

    Shanghai General Hospital, Shanghai

    Registry updated 2026-01-08

  • NCT05465252

    Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression

    Trial Treatment · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai

    Registry updated 2026-01-02

  • NCT07085533

    Natural History Study of Inherited Retinal Diseases

    Research · Augelux Therapeutics

    Renmin Hospital of Wuhan University, Wuhan

    Registry updated 2025-12-10

  • NCT07189169

    QA108 Phase III Study in Subjects With Intermediate AMD

    Trial Treatment · Phase 3 · Smilebiotek Zhuhai Limited

    Beijing Hospital, Beijing

    Registry updated 2025-09-23

  • NCT06672536

    Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD

    Trial Treatment · Phase 1/2 · Sinocelltech Ltd.

    Tianjin Medical University Eye Hospital, Tianjing

    Registry updated 2025-09-04

  • NCT07063251

    An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease

    Trial Treatment · Early phase 1 · HuidaGene Therapeutics Co., Ltd.

    Eye ENT Hospital of Fudan University, Shanghai

    Registry updated 2025-08-27

  • NCT06859515

    A Long-term Follow up Study of EXG102-031 in Participants With wAMD

    Research · Guangzhou Jiayin Biotech Ltd

    Peking University People's Hospital, Beijing

    Registry updated 2025-08-15

  • NCT07002372

    Effect of Video Viewing on Intravitreal Injection Experience

    Trial Treatment · Second Affiliated Hospital, Zhejiang University, School of Medicine

    Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

    Registry updated 2025-06-03

All Macular degeneration trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Under construction, not live – Macular degeneration trials in China – Frontlight Research